Marc Harrison

New Players Disrupting the Healthcare and R&D Landscape

Dan Mendelson, Marc Harrison, Thomas Moriarty, Mario Schlosser, Benjamin Seet, Sue Siegel, David Freeman, Jr., Margot Sanger

Industry leaders from Intermountain Healthcare, CVS Health, Oscar Health, ASTAR, and GE Health converge to address the unsustainable trajectory of U.S. and global healthcare costs through a strategic shift from volume-based to value-driven payment models. The discussion highlights critical initiatives including Intermountain's standalone generic drug venture, CVS's integration of pharmacists into community care hubs, and Oscar's full-stack technology infrastructure designed to leverage telemedicine for acute condition management. While these organizations and non-traditional entrants like Amazon and tech giants in Asia drive innovation, they simultaneously navigate systemic barriers such as data interoperability failures, consumer financial toxicity, and the complex challenge of scaling digital adoption across diverse demographics.